Jay P Heiken, MD,
Mallinckrodt Institute of Radiology,
510 South Kingshighway Blvd.,
St Louis, MO 63110, USA
Colorectal cancer screening reduces mortality in individuals 50 years and older. Each of the screening tests currently available has advantages and limitations, and there is no consensus as to which test or combination of tests is best. What is clear, however, is that the rates of colorectal cancer screening remain low. This review summarizes the clinical evidence supporting colorectal cancer screening in the average risk population and in high risk groups, discusses the advantages and disadvantages of the available screening tests, outlines the currently recommended guidelines for screening based on risk category, and discusses new and emerging technologies for colorectal cancer screening.
Cancer Imaging • e-ISSN 1470-7330 • Print ISSN 1740-5025 • Published on behalf of the International Cancer Imaging Society by e-MED Ltd
Company Number: 03911815 Instituted in Cardiff • PO Box 518, Beckenham BR3 9HN, UK • Tel: +44 (0) 20 8650 1434
E-mail: firstname.lastname@example.org • Web: www.e-med.org.uk